PHARMACY

Novo Nordisk provides funding for diabetes initiatives

BY Alaric DeArment

NEW YORK — Diabetes organizations in several cities are getting a boost in funding from a Danish drug maker that specializes in developing treatments for the disease.

Novo Nordisk said it would provide funding to groups in Seattle; Portland, Ore.; and Rochester, Minn., as part of the Novo Nordisk Community Care initiative. The initiative provides funding to nonprofits that support educational programs for people with Type 2 diabetes.

Groups in Seattle receiving funding include the Center for MultiCultural Health, the EvergreenHealth Foundation, Senior Services and the University of Washington Foundation. In Portland, recipients include the African American Health Coalition, the Harold Schnitzer Diabetes Health Center at Oregon Health and Science University, Legacy Health and the Wallace Medical Concern. The Mayo Clinic and Migrant Health Service are the groups in Rochester receiving funding.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

Shire launches ulcerative colitis information site

BY Alaric DeArment

CHESTERBROOK, Pa. — Drug maker Shire has launched an online information website for patients in the United States with ulcerative colitis, the company said Thursday.

The website, Shire UCentral, includes information for patients and caregivers. UC is a chronic disease that causes inflammation in the lining of the colon and rectum.

"The patient is at the heart of everything we do at Shire, and that includes Shire UCentral, which was designed with patient needs in mind and to provide an optimal viewing experience on smartphones, tablets or desktop computers," Shire Gastrointestinal Business Unit head Roger Adsett said. "Our new online resource center also reflects Shire’s commitment to being a leader in gastroenterology."

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

Alliance Boots ceases acquisition talks for Mexican wholesaler

BY Michael Johnsen

ZUG, Switzerland — Following reports in the media in Mexico and Chile of discussions between Alliance Boots and Grupo Casa Saba and its shareholders, Alliance Boots on Wednesday confirmed that it has stopped all discussions with Casa Saba and its shareholders in connection with an investment in Casa Saba or a purchase of certain of Casa Saba’s assets. 

Alliance Boots’ decision not to invest has been based on its inability to determine the current financial situation of Casa Saba, the company reported. 

Casa Saba is a distributor of pharmaceutical, health, beauty and consumer products, as well as general merchandise and publications, in Mexico.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES